[ad_1] Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce today that Swansea University Medical School is planning a clinical trial with Iota / kappa-carrageenan nasal spray as a COVID-19 prophylaxis for healthcare professionals (ICE-COVID) . The investigator-initiated study in Swansea will recruit 480 healthcare professionals who …
Read More »
[ad_1] Reviewed by Emily Henderson, B.Sc.November 23, 2020 Implanting a device into the brain to generate a rough perception of vision for people with blindness may sound like science fiction, but researchers at the University of Texas at Dallas and partner institutions aim to make that vision a reality. The …
Read More »
[ad_1] Reviewed by Emily Henderson, B.Sc.November 23, 2020 A study by Ohio State University Comprehensive Cancer Center researchers – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) described a potential therapeutic cancer vaccine that liberates suppressed immune cells that kill cancer, allowing them to …
Read More »
[ad_1] Pfizer logo of the American pharmaceutical company. yunhap news On the 20th (local time), US pharmaceutical company Pfizer and Germany’s Bioentech applied for the emergency use of a new vaccine against coronavirus infection (Corona 19) jointly developed by the US Food and Drug Administration (FDA). . It plans to …
Read More »
[ad_1] On the one hand, those who do not hide their hostility towards the future vaccine against Covid-19, on the other, those who do not hesitate for a moment to volunteer to help scientific research. Here is the moving testimony of a Covid Warrior, Leila, AFP journalist. Free her doubts, …
Read More »
[ad_1] Reviewed by Emily Henderson, B.Sc.November 16, 2020 The first ever randomized Phase 3 clinical trial in patients with advanced anal canal cancer is now open and enrolling patients. Anal cancer is a rare disease. The vast majority (90%) of new cases are of the squamous cell type, associated with …
Read More »
[ad_1] Reviewed by Emily Henderson, B.Sc.November 15, 2020 A single daily pill that combines blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to recent research presented in a study today. late …
Read More »